Skip to main content
Equibles

BANK OF MONTREAL /CAN/

Bank

Position in LGND — Ligand Pharmaceuticals Inc

CIK 927971 TORONTO, A6
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$7,054,494
-$10,151,940 QoQ
Shares Held
22,318
-74.1% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 415 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names. LGND ranks #13 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 427,448 $212,326,240
2 HALO
Halozyme Therapeutics, Inc.
 942,432 $73,764,150
3 ARGX
Argenx SE
 77,213 $71,635,902
4 REGN
Regeneron Pharmaceuticals, Inc.
 103,247 $64,378,631
5 JAZZ
Jazz Pharmaceuticals plc
 242,063 $58,329,919
6 TGTX
Tg Therapeutics, Inc.
 515,981 $28,347,995
7 MRNA
Moderna, Inc.
 389,789 $27,296,921
8 CYTK
Cytokinetics Inc
 285,688 $24,337,759

All Filings in LGND

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,054,494 22,318
2026-03-31 $17,206,434 86,183
2025-12-31 $23,834,730 126,063
2025-09-30 $22,278,719 125,769
2025-06-30 $650,930 5,726
2025-03-31 $586,574 5,579
2024-12-31 $492,673 4,598
2024-09-30 $437,593 4,372
2024-06-30 $355,745 4,222
2024-03-31 $302,706 4,141
2023-12-31 $282,037 3,949
2022-03-31 $503,167 4,473
2021-12-31 $702,946 4,551
2021-09-30 $809,447 5,810
2021-06-30 $179,730 1,370
2021-03-31 $217,087 1,424
2020-12-31 $315,354 3,171
2020-09-30 $166,998 1,752
2020-06-30 $246,291 2,202
2020-03-31 $27,922 384